Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.16
+0.20 (4.03%)
Nov 21, 2024, 2:53 PM EST - Market open
Solid Biosciences Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Solid Biosciences stock have an average target of 17.5, with a low estimate of 9.00 and a high estimate of 40. The average target predicts an increase of 239.15% from the current stock price of 5.16.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SLDB stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 6 | 7 | 7 | 7 | 7 | 6 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $15 → $12 | Buy | Maintains | $15 → $12 | +132.56% | Nov 12, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +190.70% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +210.08% | Nov 7, 2024 |
| Barclays | Barclays | Buy Maintains $18 → $15 | Buy | Maintains | $18 → $15 | +190.70% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +210.08% | Aug 14, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
382.50K
EPS This Year
-2.79
from -4.83
EPS Next Year
-2.72
from -2.79
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 3.2M | n/a | ||
| Avg | n/a | 382,500 | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.67 | -2.18 | -1.91 | ||
| Avg | -2.79 | -2.72 | -2.80 | ||
| Low | -2.91 | -3.42 | -3.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.